Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Fuhr

Showing results (81-90 of 86) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 86 results.
Pharmacogenetics|April 1, 1996
Evaluation of caffeine as a test drug for CYP1A2, NAT2 and CYP2E1 phenotyping in man by in vivo versus in vitro correlationsU Fuhr, K L Rost, R Engelhardt, et al.
International Journal of Clinical Pharmacology and Therapeutics|March 29, 2005
Pharmacokinetics of ibuprofen sodium dihydrate and gastrointestinal tolerability of short-term treatment with a novel, rapidly absorbed formulationF Sörgel, U Fuhr, M Minic, et al.
International Journal of Clinical Pharmacology and Therapeutics|December 31, 2002
Population pharmacokinetics of cyclophosphamide, doxorubicin and etoposide in 30 patients with BEACOPP chemotherapyS Wilde, A Jetter, M Zaigier, et al.
The Pharmacogenomics Journal|April 27, 2005
Pharmacogenomics education: International Society of Pharmacogenomics recommendations for medical, pharmaceutical, and health schools deans of educationD Gurwitz, J E Lunshof, G Dedoussis, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 27, 2005
Effect of propiverine on cytochrome P450 enzymes: a cocktail interaction study in healthy volunteersD Tomalik-Scharte, A Jetter, M Kinzig-Schippers, et al.
Clinical Pharmacology and Therapeutics|January 10, 2008
Effect of an antiretroviral regimen containing ritonavir boosted lopinavir on intestinal and hepatic CYP3A, CYP2D6 and P-glycoprotein in HIV-infected patientsC Wyen, U Fuhr, D Frank, et al.
Pageof 9

Showing results (81-90 of 86) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 86 results.
Pharmacogenetics|April 1, 1996
Evaluation of caffeine as a test drug for CYP1A2, NAT2 and CYP2E1 phenotyping in man by in vivo versus in vitro correlationsU Fuhr, K L Rost, R Engelhardt, et al.
International Journal of Clinical Pharmacology and Therapeutics|March 29, 2005
Pharmacokinetics of ibuprofen sodium dihydrate and gastrointestinal tolerability of short-term treatment with a novel, rapidly absorbed formulationF Sörgel, U Fuhr, M Minic, et al.
International Journal of Clinical Pharmacology and Therapeutics|December 31, 2002
Population pharmacokinetics of cyclophosphamide, doxorubicin and etoposide in 30 patients with BEACOPP chemotherapyS Wilde, A Jetter, M Zaigier, et al.
The Pharmacogenomics Journal|April 27, 2005
Pharmacogenomics education: International Society of Pharmacogenomics recommendations for medical, pharmaceutical, and health schools deans of educationD Gurwitz, J E Lunshof, G Dedoussis, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 27, 2005
Effect of propiverine on cytochrome P450 enzymes: a cocktail interaction study in healthy volunteersD Tomalik-Scharte, A Jetter, M Kinzig-Schippers, et al.
Clinical Pharmacology and Therapeutics|January 10, 2008
Effect of an antiretroviral regimen containing ritonavir boosted lopinavir on intestinal and hepatic CYP3A, CYP2D6 and P-glycoprotein in HIV-infected patientsC Wyen, U Fuhr, D Frank, et al.
Pageof 9